In the News

Making Medicine The Old-Fashioned Way - NH Chronicle 2009 (Video)

PCCA’s January Pharmacist of the Month - PCAA 2008

Forty Under 40 Who Are Making a Difference - Union Leader 2007

Pharmacists Walk Legal Line - NHPR July 2006

NH 'Compounding' Pharmacy Makes Custom Medicines - Union Leader 2006

What is 17alpha Hydroxyprogesterone Caproate?

Hydroxyprogesterone caproate is a progestogen structurally related to progesterone that has been used for recurrent miscarriage and various menstrual disorders. In recurrent miscarriage associated with proven progesterone deficiency, suggested doses have been 250 to 500 mg weekly by intramuscular injection during the first half of pregnancy.

The Safety of 17alpha Hydroxyprogesterone Caproate Use in Pregnancy

The evidence for the safety of the use of 17alpha Hydroxyprogesterone Caproate, (17OHP-C), in pregnancy is well documented by animal and clinical studies. Reviews of this topic by knowledgeable authors have uniformly concluded that no evidence exists that administration of 17OHP-C in pregnancy represents a significant risk to mother, fetus or newborn.

Hydroxyprogesterone Links

• MFMU Maternal Fetal Medicine Units Network
• March of Dimes March of Dimes Website
• White Paper Critical Issues in Quality Compounding
• Wedgewood Pharmacy Compounders of 17P Hydroxyprogesterone
• ACOG American College of Obstetricians and Gynecologists
• ORGYN The Essential Resource in Obstetrics and Gynecology
• OBGYNLINX Part of the MDLinx Network
• ACOG News Release Progesterone Recommended In Certain High Risk Pregnancies to Help Prevent Preterm Birth

Contact NNEP today for more information about Hydroxyprogesterone Caproate.